The outer thigh is a preferred location because of consistent subcutaneous tissue depth and accessibility
Additionally, the consumption of modern healthcare products is shifting away from traditional ones due to the growing number of middle-class households and rising consumer discretionary income
[1] In the SURMOUNT-1 clinical trial, higher doses in non-diabetic adults demonstrated significant weight loss, with participants losing approximately 15-20% of body weight over 72 weeks
In a 2024 study by Epic Research , semaglutide was the only GLP-1 receptor agonist that lowered the risk of anxiety in nondiabetic patients when compared to non-GLP-1 receptor agonist weight loss medications
The medication has a half-life of approximately one week, meaning most of the drug is cleared from your system in about five weeks (approximately five half-lives) after your last dose
These symptoms are not typical issues to self-manage with an over-the-counter patch and may need urgent evaluation